MwanzoME • NASDAQ
add
23andMe Holding Co.
$ 0.39
Baada ya Saa za Kazi:(5.55%)+0.022
$ 0.41
Imefungwa: 28 Jun, 20:00:00 GMT -4 · USD · NASDAQ · Kanusho
Bei iliyotangulia
$ 0.42
Bei za siku
$ 0.39 - $ 0.44
Bei za mwaka
$ 0.35 - $ 2.03
Thamani ya kampuni katika soko
183.57M USD
Wastani wa hisa zilizouzwa
4.49M
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(USD) | Mac 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato | 64.03M | -30.69% |
Matumizi ya uendeshaji wa biashara | 53.15M | -51.42% |
Mapato halisi | -208.83M | -225.80% |
Kiwango cha faida halisi | -326.16 | -370.04% |
Mapato kwa kila hisa | -0.43 | -206.96% |
EBITDA | -22.06M | 64.57% |
Asilimia ya kodi ya mapato | -0.01% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
(USD) | Mac 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 216.49M | -44.04% |
Jumla ya mali | 395.17M | -58.08% |
Jumla ya dhima | 206.65M | -9.63% |
Jumla ya hisa | 188.52M | — |
hisa zilizosalia | 490.26M | — |
Uwiano wa bei na thamani | 1.11 | — |
Faida inayotokana na mali | -13.02% | — |
Faida inayotokana mtaji | -18.11% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
(USD) | Mac 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato halisi | -208.83M | -225.80% |
Pesa kutokana na shughuli | -25.78M | 42.65% |
Pesa kutokana na uwekezaji | -2.15M | 34.73% |
Pesa kutokana na ufadhili | 2.00M | -23.25% |
Mabadiliko halisi ya pesa taslimu | -25.93M | 43.57% |
Mtiririko huru wa pesa | 50.88M | 282.19% |
Kuhusu
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
Apr 2006
Makao Makuu
Tovuti
Wafanyakazi
571